BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22288321)

  • 1. The discontinuation rate and reasons for discontinuation of implanon at the family planning clinic of University of Nigeria Teaching Hospital (UNTH) Enugu, Nigeria.
    Ezegwui HU; Ikeako LC; Ishiekwene CI; Oguanua TC
    Niger J Med; 2011; 20(4):448-50. PubMed ID: 22288321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, efficacy and acceptability of implanon a single rod implantable contraceptive (etonogestrel) in University of Benin Teaching Hospital.
    Aisien AO; Enosolease ME
    Niger J Clin Pract; 2010 Sep; 13(3):331-5. PubMed ID: 20857796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implanon sub-dermal implants: a 10-month review of acceptability in Jos, North-Central Nigeria.
    Mutihir JT; Daru PH
    Niger J Clin Pract; 2008 Dec; 11(4):320-3. PubMed ID: 19320403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of early implant discontinuation among low-income women.
    Kalmuss D; Davidson AR; Cushman LF; Heartwell S; Rulin M
    Fam Plann Perspect; 1996; 28(6):256-60. PubMed ID: 8959415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of depot medroxyprogesterone acetate (DMPA) injectable contraceptive in Enugu, Nigeria.
    Hu E; Ikeako LC; Obiora-Okafor NC
    Niger J Med; 2012; 21(3):266-71. PubMed ID: 23304918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One year study of Implanon on the adverse events and discontinuation.
    Chaovisitsaree S; Piyamongkol W; Pongsatha S; Morakote N; Noium S; Soonthornlimsiri N
    J Med Assoc Thai; 2005 Mar; 88(3):314-7. PubMed ID: 15962637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuation pattern among IUCD users at the family planning clinic, University College Hospital, Ibadan.
    Okunlola MA; Owonikoko KM; Roberts OA; Morhason-Bello IO
    J Obstet Gynaecol; 2006 Feb; 26(2):152-6. PubMed ID: 16483976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications for removal of etonogestrel implant within two years of use in Jos, Nigeria.
    Mutihir JT; Nyango DD
    East Afr Med J; 2010 Nov; 87(11):461-4. PubMed ID: 23457809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year assessment of women receiving sub-dermal contraceptive implant at Siriraj Family Planning Clinic.
    Thamkhantho M; Jivasak-Apimas S; Angsuwathana S; Chiravacharadej G; Intawong J
    J Med Assoc Thai; 2008 Jun; 91(6):775-80. PubMed ID: 18697372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contraception with levonorgestrel subdermal implants (Norplant) in Benin-City, Nigeria: a 12-year review.
    Aisien AO
    Afr J Reprod Health; 2007 Apr; 11(1):90-7. PubMed ID: 17982951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing unmet need for long-acting family planning in Ethiopia: uptake of single-rod progestogen contraceptive implants (Implanon) and characteristics of users.
    Asnake M; Henry EG; Tilahun Y; Oliveras E
    Int J Gynaecol Obstet; 2013 Nov; 123 Suppl 1():e29-32. PubMed ID: 24035007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilisation of family planning services at the teaching hospital in Blantyre, Malawi.
    Lema VM; Mtimavalye LA; Gondwe EE
    East Afr Med J; 1994 Nov; 71(11):703-11. PubMed ID: 7859653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side effects and acceptability of Implanon: a pilot study conducted in eastern Turkey.
    Yildizbas B; Sahin HG; Kolusari A; Zeteroglu S; Kamaci M
    Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):248-52. PubMed ID: 17763263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jadelle subdermal implants. Preliminary experience in a teaching hospital in the Niger Delta Region of Nigeria.
    Enyindah CE; Kasso T
    Niger J Med; 2011; 20(2):270-4. PubMed ID: 21970242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient satisfaction with a levonorgestrel-releasing contraceptive implant. Reasons for and patterns of removal.
    Haugen MM; Evans CB; Kim MH
    J Reprod Med; 1996 Nov; 41(11):849-54. PubMed ID: 8951137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contraceptive efficacy and side effects of Implanon.
    Gezginc K; Balci O; Karatayli R; Colakoglu MC
    Eur J Contracept Reprod Health Care; 2007 Dec; 12(4):362-5. PubMed ID: 17853166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acceptance rate of intrauterine contraceptive device (IUCD) amongst family planning clinic users in Lagos University Teaching Hospital (LUTH).
    Adegbola O; Ogedengbe OK
    Nig Q J Hosp Med; 2008; 18(4):175-80. PubMed ID: 19391314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users.
    Wong RC; Bell RJ; Thunuguntla K; McNamee K; Vollenhoven B
    Contraception; 2009 Nov; 80(5):452-6. PubMed ID: 19835719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with Norplant at a Nigerian teaching hospital.
    Mutihir JT; Aisien AO; Ujah IA
    East Afr Med J; 2010 Nov; 87(11):456-60. PubMed ID: 23457808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia.
    Harvey C; Seib C; Lucke J
    Contraception; 2009 Dec; 80(6):527-32. PubMed ID: 19913146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.